Excise valuation and optional exemption conditions limit pharmaceutical pricing adjustments and require fresh reassessment of deductions.

Valuation of pharmaceutical goods under Section 4(1)(a) could not be based on the Drug (Prices Control) Order, 1987 where that order fixed only the retail price and not the wholesale price, and the goods were sold below the maximum retail price. The statutory condition for applying the departmental valuation method was therefore not met. The exemption under Notification No. 245/83, being conditional and optional, could not be thrust on the manufacturer, and deductions could not be limited merely on that basis. Valuation was required to be reconsidered under the general rule after allowing admissible deductions in accordance with law, and the matter was sent for fresh determination.

---

---

Issues: (i) Whether the assessable value of the pharmaceutical goods could be determined by applying the price fixed under the Drug (Prices Control) Order, 1987 for the purpose of Section 4(1)(a) of the Central Excise Act, 1944. (ii) Whether the assessee could be compelled to accept the benefit of the exemption under Notification No. 245/83 and be denied deductions beyond the limited discount allowed by the department.

Issue (i): Whether the assessable value of the pharmaceutical goods could be determined by applying the price fixed under the Drug (Prices Control) Order, 1987 for the purpose of Section 4(1)(a) of the Central Excise Act, 1944.

Analysis: The valuation provision relied on by the department applies where goods are sold at a price fixed under law, or at the maximum price fixed under such law, and where the goods are sold in wholesale trade at the relevant place and time of removal. The order under the Drug (Prices Control) Order, 1987 fixed only the retail price and not the wholesale price. The assessee was also selling the goods at a price below the maximum retail price. On these facts, the statutory condition for applying the clause invoked by the department was not satisfied.

Conclusion: The price fixed under the Drug (Prices Control) Order, 1987 could not be applied in the manner sought by the department for valuation under Section 4(1)(a) of the Central Excise Act, 1944.

Issue (ii): Whether the assessee could be compelled to accept the benefit of the exemption under Notification No. 245/83 and be denied deductions beyond the limited discount allowed by the department.

Analysis: The notification granted exemption only on fulfilment of specified conditions, including the manner in which the retail price and price list were to be maintained and the claim for exemption was to be made. The existence of those conditions showed that the exemption was optional and could not be imposed on a manufacturer who did not seek it. The department therefore could not thrust the notification on the assessee and restrict deductions on that basis alone.

Conclusion: The exemption under Notification No. 245/83 could not be thrust upon the assessee, and the assessee remained entitled to lawful deductions as admissible.

Final Conclusion: The valuation had to be reconsidered under the general rule in Section 4(1)(a), after examining the admissible deductions in accordance with law, and the matter required fresh determination by the Assistant Commissioner.

Ratio Decidendi: Where the statutory valuation clause depends on sale at a price fixed by law or at the maximum price so fixed, it cannot be applied when the law fixes only a retail price and the goods are sold below that maximum; an exemption notification conditioned on specified compliance cannot be forced upon an assessee who does not claim it.

---